Stay updated with breaking news from Nir drayman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Could a drug given to dogs to treat cancer fight Covid? dailymail.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailymail.co.uk Daily Mail and Mail on Sunday newspapers.
Potential COVID-19 Treatment, Masitinib Inhibits SARS-CoV-2 Replication in Mice genengnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from genengnews.com Daily Mail and Mail on Sunday newspapers.
AB Science SA (Euronext - FR0010557264 - AB) today announces publication of a peer-reviewed article titled ‘ Masitinib is a broad coronavirus 3CL inhibitor that effectively blocks replication of SARS-CoV-2 in the journal Science [1]. The article reports on research that identifies masitinib as a broad antiviral agent capable of treating SARS-CoV-2 (the virus that causes COVID-19), including demonstration of in vivo activity in mice, with efficacy maintained, in vitro, against SARS-CoV-2 variants of concern. This article and its accompanying online supplemental material are accessible online from the journal website: https://science.sciencemag.org/lookup/doi/10.1126/science.abg5827 Research led by Professor Savas Tay and Dr. Nir Drayman from the Pritzker School for Molecular Engineering (University of Chicago, USA) screened a library of 1,900 clinically safe drugs and identified masitinib as the most potent inhibitor of the main target responsible for ....
Existing drug is shown to inhibit Covid virus miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
Existing drug is shown to inhibit SARS-CoV-2 virus eurekalert.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eurekalert.org Daily Mail and Mail on Sunday newspapers.